GLP-1RAs have diverse effects, including alleviating neuroinflammation and pain in OA, reducing food intake and improving body weight, protecting peripheral nerves, maintaining astrocyte function and metabolic homeostasis, and showing potential therapeutic benefits in AD and PD
Figure 1 Hemodynamic dysregulation is a fundamental pathological driver of DKD, acting synergistically with metabolic disturbances to accelerate disease progression (60)
The judge reserved judgment on this application
Managing common side effects Like other weight loss medications, tirzepatide can also cause mild to moderate gastrointestinal side effects such as nausea (most common), diarrhea, and constipation, especially during the start of treatment or when the dose is increased
This patented technology uses select nutrients to not only support but also stimulate specific cellular processes